Manual checks missed fraud in global trials. ML now flags 99% of duplicate outcomes and predicts timelines to within 2 weeks.
A platform provider for the pharmaceutical industry and regulators like the FDA, managing clinical trials where 80% finish late and delays cost millions in lost patent exclusivity.
Clinical researchers struggled to consolidate longitudinal data across global sites while adhering to strict data residency laws in the US, Europe,...
“Around 80% of clinical trials finish late, and that can have a huge financial impact. A patent for a new drug lasts 25 years, but it can take 14 years to get it to market. The faster companies can safely conduct the trials, the longer they’ll have to sell the drug exclusively on the market before the patent expires.”
Risk-based quality management platform for clinical trial oversight.
Multi-cloud developer data platform for building and scaling applications.
Related implementations across industries and use cases
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Teams spent weeks manually merging trial data. AI now generates drafts with full lineage, shifting experts to verification.
Writers averaged 2.3 reports/year. Teams now generate 300-page regulatory drafts in minutes, cutting writing time by 90%.
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Complex medical catalogs forced buyers to rely on reps for routine orders. Now, AI adapts to real-time behavior to drive self-service.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Hundreds of pages per board book slowed director prep. Now, isolated AI securely condenses sensitive materials into actionable briefs.
Custom hardware bottlenecked imaging. A switch to software-defined GPUs now renders photorealistic 3D hearts in real time.